Dabur, Himalaya flag supply chain strain as India nutraceuticals chase $100B by 2030
Executives warn replenishment, cold-chain and SKU sprawl are buckling under distribution-width strategies spanning 60 lakh kirana stores, quick-commerce and Tier-2/3 networks. With 5,000+ SKUs in play, brands are prioritising reach over depth — a structural risk as the category scales toward $100B.
What happened
Dabur India · Dabur, Himalaya and ex-P&G executives warn India's nutraceutical sector, targeting $100B by 2030, is straining replenishment, cold-chain and SKU
Key facts
- $100 billion by 2030
- 5,000 SKUs
- 60 lakh stores
Why this matters
Fragmented nutraceutical supply chains create M&A openings in cold-chain logistics, last-mile fulfillment, and SKU-lean D2C brands that can plug into incumbents' reach without the complexity tax.
Also reported by
- The Hindu BusinessLine — Same time